A detailed history of Prudential PLC transactions in Pfizer Inc stock. As of the latest transaction made, Prudential PLC holds 469,028 shares of PFE stock, worth $12.9 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
469,028
Previous 436,151 7.54%
Holding current value
$12.9 Million
Previous $12.1 Million 8.43%
% of portfolio
0.09%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$25.26 - $29.6 $830,473 - $973,159
32,877 Added 7.54%
469,028 $13.1 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $2.71 Million - $3.11 Million
104,603 Added 31.55%
436,151 $12.1 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $4.3 Million - $5.58 Million
-164,538 Reduced 33.17%
331,548 $9.55 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $206,306 - $241,151
-6,429 Reduced 1.28%
496,086 $16.5 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $91,780 - $106,188
-2,541 Reduced 0.5%
502,515 $18.4 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $282,465 - $367,728
-7,171 Reduced 1.4%
505,056 $20.6 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $6.64 Million - $8.66 Million
158,972 Added 45.0%
512,227 $26.3 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $2.23 Million - $2.72 Million
50,969 Added 16.86%
353,255 $15.5 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $376,427 - $446,325
8,090 Added 2.75%
302,286 $15.8 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $6.36 Million - $7.88 Million
138,964 Added 89.52%
294,196 $15.2 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $582,694 - $863,747
-14,102 Reduced 8.33%
155,232 $9.17 Million
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $7.71 Million - $9.9 Million
-196,437 Reduced 53.7%
169,334 $7.28 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $31.4 Million - $35.6 Million
-874,510 Reduced 70.51%
365,771 $14.3 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $38.6 Million - $43.5 Million
-1,151,170 Reduced 48.14%
1,240,281 $44.9 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $36.2 Million - $46 Million
-1,080,411 Reduced 31.12%
2,391,451 $88 Million
Q3 2020

Oct 30, 2020

SELL
$31.75 - $37.25 $24.9 Million - $29.2 Million
-783,180 Reduced 18.41%
3,471,862 $127 Million
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $40.4 Million - $49.1 Million
-1,342,372 Reduced 23.98%
4,255,042 $139 Million
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $4.47 Million - $6.38 Million
-165,267 Reduced 2.87%
5,597,414 $183 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $66.1 Million - $75 Million
-2,008,478 Reduced 25.85%
5,762,681 $226 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $1.85 Million - $2.4 Million
57,059 Added 0.74%
7,771,159 $279 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $22 Million - $24.7 Million
595,691 Added 8.37%
7,714,100 $334 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $8.97 Million - $9.86 Million
239,316 Added 3.48%
7,118,409 $302 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $29.7 Million - $33.9 Million
-772,500 Reduced 10.1%
6,879,093 $300 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $60.4 Million - $73.3 Million
-1,752,512 Reduced 18.64%
7,651,593 $337 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $2.26 Million - $2.41 Million
-68,554 Reduced 0.72%
9,404,105 $341 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $17.8 Million - $20.7 Million
558,939 Added 6.27%
9,472,659 $336 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $8.54 Million - $9.06 Million
-256,782 Reduced 2.8%
8,913,720 $323 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $7.55 Million - $8.31 Million
-243,412 Reduced 2.59%
9,170,502 $327 Million
Q2 2017

Aug 14, 2017

BUY
N/A
9,413,914
9,413,914 $316 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.